116 results on '"Medalla, Felicita"'
Search Results
2. Increased Incidence of Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004-2016
3. Emergence of Extensively Drug-Resistant Salmonella Typhi Infections Among Travelers to or from Pakistan — United States, 2016–2018
4. Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance—Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004–2018.
5. Clinical Outcomes of Patients with Nontyphoidal Salmonella Infections by Isolate Resistance— Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2004–2018
6. Bayesian hierarchical model of ceftriaxone resistance proportions among Salmonella serotype Heidelberg infections
7. Epidemiology and Antimicrobial Resistance of Campylobacter Infections in the United States, 2005–2018
8. Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008–2012
9. 2005. Direct Hospitalization Costs Associated with Resistant and Susceptible Salmonella and Shigella Infections in the United States — 2012–2019
10. Estimated incidence of antimicrobial drug-resistant nontyphoidal Salmonella infections, United States, 2004-2012
11. Laboratory-Based Surveillance of Paratyphoid Fever in the United States: Travel and Antimicrobial Resistance
12. 165. Emergence of Extensively Drug-Resistant Salmonella enterica Serotype Typhi Infections—United States, 2008–2020
13. Ciprofloxacin-resistant Salmonella enterica serotype Typhi, United States, 1999-2008
14. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins
15. Plasmid-mediated quinolone resistance in non-typhi serotypes of salmonella enterica
16. Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002
17. 132. Emergence and Spread of Multidrug-resistant salmonella Serotype Infantis Infections in the United States, 2003–2018
18. Typhoid Fever in the US Pediatric Population, 1999–2015: Opportunities for Improvement
19. Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq — United States, 2018–2019
20. Typhoid Fever in the US Pediatric Population, 1999–2015: Opportunities for Improvement.
21. Human Salmonella infection yielding CTX-M [beta]-lactamase, United States
22. 918. Typhoid Fever in the US Pediatric Population, 1999–2015, and the Potential Benefits of New Vaccines
23. COVID-19 Vaccine Breakthrough Infections Reported to CDC--United States, January 1-April 30, 2021
24. Clinically Important Resistance among Salmonella enterica Serotype Typhi Isolates—United States, 2003–2015
25. Antimicrobial Resistance among Campylobacter Isolated from Blood in the United States, 2005–2014
26. Estimated Incidence of Antimicrobial Drug–Resistant NontyphoidalSalmonellaInfections, United States, 2004–2012
27. 828Incidence of Antimicrobial-resistant Nontyphoidal Salmonella Infections in the United States, 2004–2011
28. Increase in Resistance to Ceftriaxone and Nonsusceptibility to Ciprofloxacin and Decrease in Multidrug Resistance AmongSalmonellaStrains, United States, 1996–2009
29. Estimated Incidence of Antimicrobial Drug-Resistant Nontyphoidal Salmonella Infections, United States, 2004-2012.
30. Antimicrobial Susceptibility to Azithromycin among Salmonella enterica Isolates from the United States
31. Ciprofloxacin-ResistantSalmonella entericaSerotype Typhi, United States, 1999–2008
32. Antimicrobial Resistance among Invasive Nontyphoidal Salmonella enterica Isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007
33. CommensalEscherichia coliIsolate Resistant to Eight Classes of Antimicrobial Agents in the United States
34. SalmonellaIsolates with Decreased Susceptibility to Extended-Spectrum Cephalosporins in the United States
35. Emergence of Plasmid-Mediated Quinolone Resistance among Non-Typhi Salmonella enterica Isolates from Humans in the United States
36. HumanSalmonellaInfection Yielding CTX-M β-Lactamase, United States
37. Distribution of Multidrug-Resistant Human Isolates of MDR-ACSSuT Salmonella Typhimurium and MDR-AmpC Salmonella Newport in the United States, 2003–2005
38. HumanSalmonellaand Concurrent Decreased Susceptibility to Quinolones and Extended-Spectrum Cephalosporins
39. Increase in Nalidixic Acid Resistance among Non-Typhi Salmonella enterica Isolates in the United States from 1996 to 2003
40. Plasmid‐Mediated Quinolone Resistance in Non‐Typhi Serotypes ofSalmonella enterica
41. Hospitalization and Antimicrobial Resistance inSalmonellaOutbreaks, 1984–2002
42. Evaluation of Antimicrobial Resistance Phenotypes for Predicting Multidrug-Resistant Salmonella Recovered from Retail Meats and Humans in the United States.
43. Increase in Resistance to Ceftriaxone and Nonsusceptibility to Ciprofloxacin and Decrease in Multidrug Resistance Among SalmonellaStrains, United States, 1996–2009
44. Antimicrobial Susceptibility to Azithromycin among Salmonella entericaIsolates from the United States
45. Commensal Escherichia coliIsolate Resistant to Eight Classes of Antimicrobial Agents in the United States
46. Antimicrobial Resistance among Invasive Nontyphoidal Salmonella entericaIsolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007
47. Distribution of Multidrug-Resistant Human Isolates of MDR-ACSSuT SalmonellaTyphimurium and MDR-AmpC SalmonellaNewport in the United States, 2003–2005
48. Human Salmonella Infection Yielding CTX-M β-Lactamase, United States.
49. Emergence of Plasmid-Mediated Quinolone Resistance among Non-Typhi Salmonella entericaIsolates from Humans in the United States
50. Increase in Nalidixic Acid Resistance among Non-Typhi Salmonella entericaIsolates in the United States from 1996 to 2003
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.